Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 2/20 | 0.33 |
| ▸ | ACP1 | P24666 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25799977 | 1.00 | MEN1 (0.33) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL25800018 | 0.96 | PDE7A (0.32) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL24603948 | 0.95 | PDE7A (0.32) | ATML3MBTL1KDM4E | |
| SCHEMBL26550148 | 0.93 | MEN1 (0.31) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL24531853 | 0.92 | ALDH1A1 (0.32) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL24603977 | 0.91 | MEN1 (0.33) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL25799991 | 0.91 | MEN1 (0.33) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL24531840 | 0.91 | ALDH1A1 (0.35) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL29304833 | 0.91 | ALDH1A1 (0.35) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL24603902 | 0.91 | ATM (0.32) | MEN1KMT2AALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230212173-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC ELEMENT, COMPOSITION FOR ORGANIC OPTOELECTRONIC ELEMENT, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
| US-20230212173-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC ELEMENT, COMPOSITION FOR ORGANIC OPTOELECTRONIC ELEMENT, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212173-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC ELEMENT, COMPOSITION FOR ORGANIC OPTOELECTRONIC ELEMENT, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | OCIAD2, OCIAD1, OSTC | MEN1 2672/4885KMT2A 3580/4885ALDH1A1 123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.